MacDonald Lab

IMIan M. MacDonald MSc MD CM is a Professor in the Department of Ophthalmology and Visual Sciences, University of Alberta and recently stepped down after four terms as its Chair. From 2007-2008, he served as Branch Chief of Ophthalmic Genetics at the National Eye Institute of the NIH in Bethesda, MD. A McGill graduate in Medicine, Dr. MacDonald completed Ophthalmology residency training at the University of Ottawa and Clinical Genetics fellowship training at the University of Ottawa, Queen’s University, Kingston and the Hospital for Sick Children, Toronto. He was a Career Scientist of the Ontario Ministry of Health at the University of Ottawa prior to moving to Edmonton in 1992.

His main research interest is inherited retinal disorders, in particular, maculopathies and choroideremia. In 2009, in recognition of his work in Canada to foster the development of academic ophthalmology, he was elected to as a Fellow of the Canadian Academy of Health Sciences.

Research Support: Alberta Innovates-Health Solutions; Choroideremia Research Foundation, Canada Inc.; Foundation Fighting Blindness, Canada; Canadian Institutes for Health Research, Canadian Foundation for Innovation

References:

MacDonald IM, Moen C, Duncan JL, Tsang SH, Cehajic-Kapetanovic J, Aleman TS. Perspectives on Gene Therapy: Choroideremia Represents a Challenging Model for the Treatment of Other Inherited Retinal Degenerations. Trans Vis Sci Tech. 2020;9(3):17.

Radziwon A, Cho WJ, Szkotak A, Suh M, MacDonald IM. Crystals and Fatty Acid Abnormalities Are Not Present in Circulating Cells From Choroideremia Patients. Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4464-4470.

Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS, MacDonald IM. Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience. Am J Ophthalmol. 2018 Sep;193:130-142.

________________________________________________________________________

Matthew Benson MD is a graduate student and resident in the Department of Ophthalmology and Visual Sciences and he is completing a Master of Science degree in the MacDonald lab. He received his Medical Degree from the University of Alberta in 2015.

Matthew is particularly interested in inherited retinal dystrophies and he is currently investigating the mechanism of disease in a patient with a peroxisomal biogenesis disorder. He is the 2018 recipient of the Foundation Fighting Blindness Canada Clinician-Scientist Emerging Leader Award.

________________________________________________________________________

Geoff Casey BSc (EE), BSc (Mol Gen) is currently completing a Master of Science degree in Medical Genetics in the MacDonald lab. He has received Bachelor of Science degrees in Electrical Engineering/Nanotechnology and Molecular Biology from the University of Alberta.

Geoff is contributing to the development of novel viral vectors for the treatment of genetic ocular disorders. He is performing preclinical characterizations of viral vectors and evaluating novel methods of mitigating immune responses against these vectors.

________________________________________________________________________

Lance Doucette PhD is a Research Associate in the Department of Ophthalmology and Visual Sciences, University of Alberta under the supervision of Dr. Ian M. MacDonald since April of 2017. He completed his PhD in Human Genetics at Memorial University in 2012 where he studied the genetic cause of inherited blindness in the Newfoundland population.

In 2013, he moved to the University of Alberta as a Postdoctoral Fellow in the Department of Medical Genetics under the supervision of Dr. Michael Walter where he studied the role of a developmental gene, FOXC1 and its role in the molecular biology of glaucoma.
In Dr. MacDonald’s Laboratory, Dr. Doucette’s interest is understanding the genetics and molecular biology behind inherited ocular disorders, particularly macular and retinal dystrophies. His expertise is in identifying disease genes through next generation sequencing, and using molecular biology techniques to understand how these genes are involved in eye disease.

References:
Rasnitsyn A, Doucette L, Seifi M, Footz T, Raymond V, Walter MA. FOXC1 modulates MYOC secretion through regulation of the exocytic proteins RAB3GAP1, RAB3GAP2 and SNAP25. PLoS One.2017 Jun 2;12(6):e0178518.

Doucette LP, Rasnitsyn A, Seifi M, Walter MA. The interactions of genes, age, and environment in glaucoma pathogenesis. Surv Ophthalmol.2015 Jul-Aug;60(4):310-26.

________________________________________________________________________

Manlong

Manlong Xu MD PhD is a clinical research fellow in the Department of Ophthalmology and Visual Sciences at the University of Alberta under the supervision of Dr. Ian M. MacDonald since December 2015. She completed her PhD in Vision Science and Biology (joint degree) at University of Waterloo in 2015, where she studied the individual and combined toxicity of UV radiation and chemicals on the eye.

Previously, Dr. Xu was a physician specialized in internal medicine (with special training in rheumatology) in China, where she did clinical studies on ankylosing spondylitis and systemic lupus erythematosus (SLE).

 In Dr. MacDonald’s laboratory, Dr. Xu engages in clinical research on the natural history and gene therapy for retinal degeneration (especially choroideremia). Her research interest is visual field progression in inherited eye disorders.

References:

Xu M, Zhai Y, MacDonald IM. Visual Field Progression in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):56

Zhai Y, Xu M, Dimopoulos IS, Birch BG, Bernstein PS, Holt J, Kirn D, Francis P, & MacDonald IM. Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method. Transl Vis Sci Technol. June 2020 9(7).

Xu, M., McCanna, D.J. & Sivak, J.G. 2015, “Use of the Viability Reagent PrestoBlue in Comparison with Alamarblue and MTT to Assess the Viability of Human Corneal Epithelial Cells”, Journal of Pharmacological and Toxicological Methods, vol.71, pp. 1-7.

________________________________________________________________________

Yi (Fay) Zhai MD PhD is a clinical research fellow in the Department of Ophthalmology and Visual Sciences at the University of Alberta under the supervision of Dr. Ian M. MacDonald. After receiving her medical degree from Zhejiang University, she passed the medical licensing examination and became an ophthalmologist in China. In 2016, she completed her PhD in Medicine with an ophthalmic specialty at Zhejiang University.

Dr. Zhai has a strong clinical research interest in inherited eye disorders. Her previous research projects include congenital cataract, age-related macular degeneration and hereditary retinal degeneration. In Dr. MacDonald’s laboratory, Dr. Zhai focuses on the clinical research and genetic therapy of retinal degeneration (especially choroideremia).

References:

Zhai Y, Xu M, Dimopoulos IS, Birch BG, Bernstein PS, Holt J, Kirn D, Francis P, & MacDonald IM. Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method. Transl Vis Sci Technol. June 2020 9(7).

Xu M, Zhai Y, MacDonald IM. Visual Field Progression in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):56

Zhai Y, MacDonald IM. OCT Changes in 4-Year-Old Choroideremia Patient.  Ophthalmology. 2019 Oct;126(10):1357.

________________________________________________________________________

Jessica Lawrence MSc CGC CCGC is a genetic counsellor in the Department of Ophthalmology at the Royal Alexandra Hospital. She received her undergraduate degree in Genetics from the University of Manitoba in 2016, and her master of science degree in Genetic Counselling from McGill University in 2019. Jessica is a passionate clinical genetics professional with a strong interest in the treatment of inherited ocular disorders and the impacts of these disorders on individuals and their families.

________________________________________________________________________

Kimberly Papp BSc (immunology and infection) is a medical student at the University of Alberta. Kim is currently working with Geoff Casey in characterizing the innate immune response of retinal pigment epithelium cells, with applications in viral-mediated gene therapy.